Literature DB >> 9121311

Tenuous airway in children with trisomy 21.

A L de Jong1, M Sulek, M Nihill, N O Duncan, E M Friedman.   

Abstract

Multiple congenital anomalies are closely linked to Down syndrome (trisomy 21). Cardiac malformations are found in 40% of patients, a large number of whom will require a major surgical procedure. The importance of postextubation stridor in these children is frequently underestimated. A retrospective review of 99 trisomy 21 patients who underwent cardiovascular surgery revealed postextubation stridor in 24 (24.2%). Significant factors for the development of stridor included younger age (P=0.04), lower growth percentile for weight (P=0.03), and increased frequency of reintubation (P=0.04). Subglottic stenosis was found in 6 (6.1%). In 4 of these patients, an endotracheal tube of larger diameter than predicted for age was used. All 6 patients were less than the 10th percentile for weight. We conclude that Down syndrome patients deserve special considerations and modifications of standard intubation techniques for successful airway management.

Entities:  

Mesh:

Year:  1997        PMID: 9121311     DOI: 10.1097/00005537-199703000-00013

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Postextubation airway management with nasal continuous positive airway pressure in a child with Down syndrome.

Authors:  Hiroaki Ito; Kazuya Sobue; Min-Hye So; Takeshi Sugiura; Hiroshi Sasano; Akinori Takeuchi; Hirotada Katsuya
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

Review 2.  [Anesthesiological considerations for patients with trisomy 21 (Down syndrome)].

Authors:  K Ihringer; N Russ; A Walther; J-H Schiff
Journal:  Anaesthesist       Date:  2013-05       Impact factor: 1.041

Review 3.  Underlying factors of recurrent infections in patients with down syndrome.

Authors:  Turkan Patiroglu; Murat Cansever; Fulya Bektas
Journal:  North Clin Istanb       Date:  2018-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.